Some women with polycystic ovary syndrome (PCOS) are turning to GLP-1 drugs such as semaglutide and tirzepatide in hopes of improving their chances of getting pregnant, ABC News reported on Oct. 14. Early research suggests a possible benefit for some patients, but the drugs are not approved as fertility treatments, and the evidence remains preliminary.
PCOS, which an international group renamed polyendocrine metabolic ovarian syndrome (PMOS) in May, is one of the most common causes of infertility and is often linked to irregular ovulation and insulin resistance. For women who have spent years on fertility treatment, stories of conception after starting a GLP-1 can feel hopeful. The more practical question is how to use the drugs safely if pregnancy is the goal, because guidance calls for stopping them before trying to conceive.
